Skip to main content

Table 2 Clinical changes after a switch from etanercept to infliximab

From: Effective use of TNF antagonists

Parameter

Pre-infliximab (baseline)

Post-infliximab (4 doses; week 14)

Outcome

Mean tender joints (n)

17.1

7.3

57% reduction

Mean swollen joints (n)

11.2

3.8

66% reduction

ESR (mm/h)

33

26.5

20% reduction

Mean prednisone dosage (mg/day)

9.2

5.7

38% reduction

  1. ESR, erythrocyte sedimentation rate. Data from [17].